# BETA (BETA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹1376.7
Day Change: +11.28%
52W High: ₹2000
52W Low: ₹990.1
Market Cap: ₹1,284 Cr

## Valuation
P/E: 19.87
P/B: 2.9
EPS: ₹64
Book Value: ₹437.84
Dividend Yield: 0%

## Returns
1Y Return: -31.4%

## Profitability
ROE: 0%
ROCE: 37.71%
Debt/Equity: 0.66
Revenue Growth: -1.2%
Profit Growth: -9.8%
EBITDA Margin: 19.29%
Operating Margin: 14.44%

## About
BETA is a Pharma company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Unknown
Sub Industry: Unknown

## Business Model
Overview: BETA makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Pharma. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.

## Access
Current tier: anonymous
More history: Register free to see 5 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.755Z
Price History Updated: 2026-05-17T21:24:48.444Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:24:48.444Z
Quant Updated: 2026-05-17T21:24:48.444Z
Sentiment Updated: 2026-05-17T21:24:48.444Z
Financials Status: current
Financials Updated: 2026-05-18T10:30:01.379Z
Financials Last Attempt: 2026-05-18T10:30:01.379Z
Financials Provider Tried: database
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2019)
Revenue: ₹51 Cr
Operating Profit: ₹9 Cr (OPM 19%)
Net Profit: ₹7 Cr
Tax: ₹7 Cr

## Annual P&L History
Mar 2019: Rev ₹51Cr | PAT ₹7Cr | OPM 19%
Mar 2020: Rev ₹66Cr | PAT ₹8Cr | OPM 18%
Mar 2021: Rev ₹91Cr | PAT ₹9Cr | OPM 20%

## Balance Sheet (Mar 2019)
Total Assets: ₹50 Cr
Total Liabilities: ₹50 Cr
Borrowings: ₹8 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Rahul  Batra, Chairman & MD
- Varun  Batra, Joint MD & Whole Time Director
- Nipun  Arora, Chief Financial Officer
- Rajni  Brar, Company Secretary & Compliance Officer
- Balwant  Singh, Whole Time Director

---
Source: rupiya.io/stocks/beta
Disclaimer: For research and education only. Not investment advice.